Pulmonary tuberculosis case notification and burden of drug resistance among children under 15 years of age in Ethiopia: sub-analysis from third-round drug resistance tuberculosis survey
-
Published:2023-08-24
Issue:1
Volume:23
Page:
-
ISSN:1471-2431
-
Container-title:BMC Pediatrics
-
language:en
-
Short-container-title:BMC Pediatr
Author:
Abebaw Yeshiwork,Abebe Markos,Tola Habteyes Hailu,Mehammed Zemedu,Getahun Muluwork,Gamtesa Dinka Fikadu,Diriba Getu,Hailu Michael,Yirgu Hailegiorgis,Sheth Anandi Nayan,Argaw Rahel,Abegaz Woldaregay Erku
Abstract
Abstract
Introduction
Data on the burden of bacteriologically confirmed childhood Tuberculosis (PTB) and drug-resistant TB in Ethiopia is limited due to difficulties related to its diagnosis in this population. Therefore, this study aimed to assess bacteriologically confirmed childhood PTB Case Notification Rates (CNRs) and the burden of Drug Resistant-Tuberculosis among children in Ethiopia.
Method
Retrospective secondary clinical and laboratory data were obtained from 3rd round national DR-TB survey which was conducted between August 2017 and January 2019. We used IBM SPSS 24 for sub-analysis of 3rd round Drug Resistant-Tuberculosis data. Descriptive statistics were used in computing the association between the sociodemographic characteristics and PTB CNRs, and the strength of the associations was determined using binary logistic regression with Odds ratios (OR) with a 95% confidence interval (CI).
Result
Overall, 102 bacteriologically confirmed childhood PTB cases were identified with a median age of 12 (range 1–14) years. Of these, 54 (52.9%) were females and 81 (79.4%) lived in rural areas. HIV-TB co-infection cases were 5/102 (4.3%) and the majority (98%) of cases were newly diagnosed children. Nationally, the incidence of bacteriologically confirmed childhood PTB was calculated to be 5.1 per 100,000 children. The burden of Drug Resistant-Tuberculosis to at least one of the five first-line anti-TB drugs tested was five (6.5%) cases and one (1.3%) was found to be a Multi-drug resistant tuberculosis case. Drug-resistant tuberculosis was significantly associated with the age group 10–14 years (P = 0.002; [AOR] 29.76; [95% CI, 3.51-252.64]) and children living in urban areas (P = 0.027; [AOR] 5.76; 95% CI, 1.22–27.09).
Conclusion
Bacteriologically confirmed childhood PTB cases increased as the age of the children increased. Most of the bacteriologically confirmed childhood PTB and the identified drug Resistant-Tuberculosis cases were new cases. Also, rural children were more affected by TB than their urban, counterparts Drug Resistant-Tuberculosis was higher in urban resident children.
Publisher
Springer Science and Business Media LLC
Subject
Pediatrics, Perinatology and Child Health
Reference50 articles.
1. The Union Silent Epidemic. : A Call To Action Against Child Tuberculosis.The Union. Available:https://theunion.org/news/photo-stories/silent-epidemic-a-call-to-action-against-child-tuberculosis.(access date May 24,2022).
2. World Health Organization. Global TUBERCULOSIS Executive summary. WHO/CDS/TB/2021.ISBN 978-92-4-003702-1.
3. Harausz P, Garcia-prats EP, Seddon AJ, Schaaf JA. New and Repurposed Drugs for Pediatric Multidrug-Resistant tuberculosis practice-based recommendations. Am J Respir Crit Care Med. 2017;195(10):1300–10.
4. Dodd PJ, Sismanidis C, Seddon JA. Global burden of drug-resistant tuberculosis in children: a mathematical modelling study. Lancet Infect Dis. 2016;3099(16):1–9.
5. Federal Democratic of Ethiopia Ministry of heath National Guideline for TB., DR-TB and leprosy in Ethiopia Addis Ababa,2018 sixth edition.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献